arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Sponsored Symposia

Friday 11 October 2019

15:30-16:30 Diagnostic workshop sponsored by

Program
Management of Invasive Candida Infections in critically ill patients: contribution of biomarkers

15:30 Invasive Candida infection in ICU patients: clinical aspects and Epidemiology
Garyphallia Poulakou, Sotiria General Hospital of Athens, Greece
15:45 discussion

15:50 Contribution of glycan biomarkers to the diagnosis of invasive Candidiasis
Boualem Sendid, Hospital Regional University Centre, Lille, France
16:05 discussion

16:10 Biomarker-based strategy for the early discontinuation of empirical anti-fungal treatment in ICU patients
Saad Nseir, Salengro Hospital, Hospital Regional University Centre, Lille, France
16:25 discussion

16:45-18:15 Integrated Symposium 1 sponsored by

Saturday 12 October 2019

12:30-14:00 Integrated Symposium 2 sponsored by

Program
Tackling invasive mould disease, one patient at a time:
The value of a patient-tailored early treatment approach

12:30 Welcome and introduction
Johan Maertens, Hematologist, UZ Leuven, Belgium

12:35 Evolving risk stratification and empowering diagnostics to ensure targeted treatment
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

12:55 Case study part 1
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

13:00 Where are we now? Epidemiology, clinical data, guidelines and challenges in the invasive mould disease landscape  
Johan Maertens, Hematologist, UZ Leuven, Belgium

13:20 Case study part 2
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria 

13:25 PK/PD patient-considerations for the appropriate treatment of IMD
Federico Pea, MD, clinical pharmacologist in charge of chemotherapy at the Institute of Clinical Pharmacology, Santa Maria della Misericordia University Hospital, Udine, Italy

13:45 Case study part 3
Robert Krause, MD, DTMP, Head of the Section of Infectious and Tropical Medicine, Department of Internal Medicine, Medical University of Graz, Austria

13:50 – 14:00  Discussion, Questions & Answers and closure
Led by Johan Maertens, Hematologist, UZ Leuven, Belgium

Click here for a PDF version of the programme

18:00-19:30 Integrated Symposium 3 sponsored by


Sunday 13 October 2019

12:30-13:00 Diagnostic symposium sponsored by 

13:00-14:00 Diagnostic workshop sponsored by

Program
(1→3)-β-glucan in the diagnosis and clinical management of invasive fungal disease

Moderator:
Malcolm Richardson, PhD, FSB, FISSE, FRCPath, FECMM, Director and Consultant Clinical Scientist in Mycology – Manchester University NHS Foundation Trust,  Professor of Medical Mycology – University of Manchester, United Kingdom

 (1→3)-β-glucan in the diagnosis and clinical management of invasive fungal disease: From laboratory investigation to patient care
Thomas J. Walsh, MD
Professor of Medicine in Microbiology & Immunology,
Professor of Medicine in Pediatrics, Weill College of Medicine at Cornell University, New York, NY USA